A double-blind, placebo-controlled, randomized, parallel-group multicenter study of mometasone furoate nasal spray on sleep disturbances and daytime somnolence in subjects with symptomatic seasonal allergic rhinitis.

Trial Profile

A double-blind, placebo-controlled, randomized, parallel-group multicenter study of mometasone furoate nasal spray on sleep disturbances and daytime somnolence in subjects with symptomatic seasonal allergic rhinitis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Dec 2014

At a glance

  • Drugs Mometasone (Primary)
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors Schering-Plough
  • Most Recent Events

    • 16 Mar 2010 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
    • 16 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Feb 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top